Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pharyngitis01:23

Chronic Pharyngitis

505
Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
505
Hearing01:31

Hearing

51.1K
When we hear a sound, our nervous system is detecting sound waves—pressure waves of mechanical energy traveling through a medium. The frequency of the wave is perceived as pitch, while the amplitude is perceived as loudness.
51.1K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

85
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
85
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

355
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
355
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

360
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
360
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

932
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
932

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Large language model applications in facial plastic and reconstructive surgery: a systematic review of applications, performance, and ethical considerations.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·2026
Same author

Hybrid external-endoscopic wendler glottoplasty: achieving scarless anterior synechia in the challenging larynx.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·2026
Same author

Predictors of multidisciplinary tumor board implementation in head and neck cancer: Global insights.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·2026
Same author

Comparing Straw-Based Semi-Occluded Vocal Tract Exercises (SOVTEs): From Air Phonation to Water Resistance Therapy-A Scoping Review.

Journal of voice : official journal of the Voice Foundation·2026
Same author

Systemic Treatments for Recurrent or Metastatic Sinonasal Carcinomas: A Retrospective Multicenter Study.

Head & neck·2026
Same author

Bioethics committee approvals in multicentre laryngology research across Europe: the European Laryngological Society's consensus on legal basis and quality assurance.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·2026

Related Experiment Video

Updated: May 7, 2025

Author Spotlight: Optimizing EAS with Long Electrodes for Enhanced Cochlear Coverage and Hearing Preservation
03:49

Author Spotlight: Optimizing EAS with Long Electrodes for Enhanced Cochlear Coverage and Hearing Preservation

Published on: October 11, 2024

672

Treating Presbyphonia in 2024: A Scoping Review.

Ralph Haddad1, Estelle Bogdanski1, Alexia Mattei1

  • 1Department of Oto-Rhino-Laryngology and Head and Neck Surgery, AP-HM, Marseille, La Conception University Hospital, Aix-Marseille University, 147 Boulevard Baille, CEDEX 5, 13385 Marseille, France.

Journal of Voice : Official Journal of the Voice Foundation
|December 31, 2024
PubMed
Summary

Presbyphonia treatment requires a comprehensive approach, addressing overall health and specific vocal fold issues. Voice therapy is recommended initially, with office-based medialization for severe cases to improve voice quality.

Keywords:
Presbyphonia—Aging voice—Voice therapy—Medialization—Regenerative medicine.

More Related Videos

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss
09:44

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss

Published on: January 25, 2016

19.1K
Systematic Hearing Performance Evaluation Process for Adolescents with Cochlear Implantation at Early Ages
06:04

Systematic Hearing Performance Evaluation Process for Adolescents with Cochlear Implantation at Early Ages

Published on: March 24, 2023

307

Related Experiment Videos

Last Updated: May 7, 2025

Author Spotlight: Optimizing EAS with Long Electrodes for Enhanced Cochlear Coverage and Hearing Preservation
03:49

Author Spotlight: Optimizing EAS with Long Electrodes for Enhanced Cochlear Coverage and Hearing Preservation

Published on: October 11, 2024

672
Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss
09:44

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss

Published on: January 25, 2016

19.1K
Systematic Hearing Performance Evaluation Process for Adolescents with Cochlear Implantation at Early Ages
06:04

Systematic Hearing Performance Evaluation Process for Adolescents with Cochlear Implantation at Early Ages

Published on: March 24, 2023

307

Area of Science:

  • Gerontology
  • Otolaryngology
  • Speech-Language Pathology

Background:

  • Presbyphonia, an age-related voice disorder, presents complex multifactorial challenges.
  • Effective management necessitates addressing both systemic aging factors and laryngeal dysfunction.
  • Geriatric frailty and medication side effects can exacerbate vocal changes.

Purpose of the Study:

  • To outline a comprehensive, evidence-based treatment strategy for presbyphonia.
  • To propose a tiered therapeutic approach prioritizing non-invasive interventions.
  • To identify optimal interventions for glottal gap closure and vocal fold pliability.

Main Methods:

  • A literature scoping review was conducted to synthesize current evidence on presbyphonia management.
  • The review focused on identifying effective voice therapies and minimally invasive laryngeal procedures.
  • Treatment recommendations were formulated based on patient vocal demands and severity of glottal gap.

Main Results:

  • Voice therapy, incorporating diverse exercises, is proposed as the primary treatment to enhance voice quality.
  • Office-based medialization with hyaluronic acid injection is recommended as a first-line intervention for significant glottal gaps or high vocal demands.
  • Platelet-rich plasma injections may complement medialization to improve mucosal vibratory function.

Conclusions:

  • A holistic management strategy combining global health optimization and targeted laryngeal therapies is crucial for presbyphonia.
  • A stepwise approach, starting with voice therapy and progressing to office-based medialization, offers a tailored treatment pathway.
  • Minimally invasive procedures like hyaluronic acid and PRP injections provide effective options for improving vocal function in presbyphonia.